MeiraGTx seeks UK approval after gene therapy restores sight in children born blind
MeiraGTx’s investigational gene therapy AAV-AIPL1 has improved the sight of 11 children who were born blind.
Cytiva-Cell & Gene Therapy WP 2
A2 Biotherapeutics raises $80m to advance CAR-T therapies for solid tumours
GEMMABio raises $34m to advance gene therapy programmes
Takeda and Alloy Therapeutics partner to make off-the-shelf CAR-T therapies
Intellia’s gene editing therapy shows early potential in rare heart condition
bit.bio defends European patent for ‘novel’ opti-ox technology
Purespring secures $105m to start Phase I/II trial of IgAN gene therapy
Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m
